Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
India’s pharma M&A market hits four-year high on blockbuster deals
14+ hour, 12+ min ago (248+ words) The Pharma Letter - India’s pharma M&A market hits four-year high on blockbuster deals India’s mergers and acquisitions (M&A) market hit a four-year high in the April to June quarter, powered by a single blockbuster: Sun Pharmaceutical Industries' (BOM:…...
Abivax builds out commercial team as it readies obefazimod for US launch
1+ day, 20+ hour ago (282+ words) The Pharma Letter - Abivax builds out commercial team as it readies obefazimod for US launch French biotech Abivax (Euronext Paris: ABVX) has hired four senior commercial executives, filling out its leadership bench as it prepares to sell its experimental bowel…...
BeOne Medicines adds $300M investment in US site
1+ day, 19+ hour ago (279+ words) The Pharma Letter - BeOne Medicines adds $300M investment in US site Sino-American oncology-focused biotech BeOne Medicines’ (Nasdaq: ONC; HKEX: 06160) announced a $300 million expansion of its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus…...
Verdiva Bio | The Pharma Letter | The Pharmaletter
1+ day, 20+ hour ago (929+ words) Verdiva Bio The Pharma Letter A UK-headquartered clinical-stage biopharmaceutical company developing once-weekly oral GLP-1 and amylin analogs for obesity and cardiometabolic disorders, backed by a $411 million Series A. Verdiva Bio launched in January 2025 with an oversubscribed financing round that was reported…...
Trump turns tariff fire on generics with 2028 countdown
2+ day, 20+ hour ago (268+ words) The Pharma Letter - Trump turns tariff fire on generics with 2028 countdown US president Donald Trump has set a countdown for tariffs on imported generic medicines, ending an exemption that had shielded the copycat drugs supplying the bulk of US prescriptions....
Kairos Pharma teams up with Bayer to enhance Xofigo activity in MPC
2+ day, 20+ hour ago (238+ words) The Pharma Letter - Kairos Pharma teams up with Bayer to enhance Xofigo activity in MPC US clinical-stage biotech Kairos Pharma (NYSE American: KAPA) saw its shares close down 12.6% at $0.31 yesterday, despite announcing a strategic collaboration with German pharma major Bayer…...
Gilead, Merck weekly HIV pill maintains suppression in Phase III switch studies
3+ day, 15+ hour ago (248+ words) The Pharma Letter - Gilead, Merck weekly HIV pill maintains suppression in Phase III switch studies US pharma majors Gilead Sciences (Nasdaq: GILD) and Merck & Co (NYSE: MRK) have reported detailed Phase III data showing that their investigational once-weekly oral HIV…...
Indian drugmakers slide as USA plans 200% generic tariff
3+ day, 15+ hour ago (219+ words) The Pharma Letter - Indian drugmakers slide as USA plans 200% generic tariff Indian pharmaceutical stocks fell sharply on July 22 after US President Donald Trump announced plans to impose steep tariffs on imported generic drugs beginning in 2028. Mr Trump said generics would…...
Latigo bets its IPO on non-opioid pain data
5+ day, 19+ hour ago (278+ words) The Pharma Letter - Latigo bets its IPO on non-opioid pain data USA-based biotech Latigo Biotherapeutics has thrown open its books to public investors, using a Friday filing with the Securities and Exchange Commission to reveal mid-stage results for its lead…...
BMS expands NVIDIA tie-up with Vera Rubin AI factory
5+ day, 16+ hour ago (248+ words) The Pharma Letter - BMS expands NVIDIA tie-up with Vera Rubin AI factory US pharma major Bristol Myers Squibb (NYSE: BMY) is expanding its partnership with NVIDIA (NASDAQ: NVDA), with plans to deploy an NVIDIA DGX SuperPOD built on DGX Vera…...